Aneurysm Cerebral
19
5
6
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 19 trials
100.0%
+13.5% vs benchmark
11%
2 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (19)
This Three-year Observational Study Involves Patients of All Ages Undergoing Endovascular Treatment for Various Cerebral or Spinal Vascular Conditions. It Aims to Assess Pre- and Post-operative Clinical Conditions, Report Complications, and Identify Preoperative Indicators of Treatment Outcomes. Pat
Derivo 2 Heal vs Derivo 2: In-Stent Stenosis After Flow Diversion
Perioperative Risk in Patients on Chronic Aspirin Undergoing Craniotomy
Optimal Duration of Dual Antiplatelet Therapy After Stent-assisted Coiling
LUMENS-1 Canada Early Feasibility Study Clinical Investigation Plan
LUMENS-1 EU EFS CIP
Psychiatric Outcomes of Unruptured Intracranial Aneurysms (POUIA)
Kaneka Endovascular Embolization and Protection
Complex Aneurysm Registry - Real-World Evidence Data Collection Intracranial Aneurysm Treatment Devices
Study to Evaluate the TUBE Device Ability to Treat Unruptured, Wide-neck or Fusiform Aneurysms
The Risk Factors Related to Rupture Flow-related Aneurysms in Posterior AVM
Blood Pressure Treatment in ICU Patients with Subarachniodal Haemorrhage.
Post Market Clinical Follow-Up Study on the Performance and Safety of Lyoplant®
Personalized Treatment Planning in Intracranial Aneurysm Surgeries.
Interest of a Simulated Procedure Performed on a Printed Model in the Endovascular Treatment of Carotid-sylvian Aneurysms
Setting Benchmarks for Microsurgical Clipping of Unruptured Intracranial Aneurysms
Dexmedetomidine Improves Recovery After Cranial Aneurysm Surgery
Comparison of Two Different Antiplatelet Preparations for an Unruptured Intracranial Aneurysm
Lidocaine and Perioperative Cytokine Levels in Blood and Cerebrospinal Fluid in Cerebral Aneurysm Patients